Literature DB >> 1940790

Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.

J A Madrigal1, M P Belich, R J Benjamin, A M Little, W H Hildebrand, D L Mann, P Parham.   

Abstract

A monomoprhic monoclonal antibody (LA45 antibody) reactive with "a new activation-induced surface structure on human T lymphocytes" (LA45 antigen) that resembled free class I heavy chains has recently been described (Schnabl, E., H. Stockinger, O. Majdic, H. Gaugitsch, I.J.D. Lindley, D. Maurer, A. Hajek-Rosenmayr, and W. Knapp. 1990. J. Exp. Med. 171:1431). This antibody was used to clone a class I-like heavy chain (LA45 gene) from the HUT 102 tumor cell, which paradoxically did not give rise to the LA45 antigen on transfection into monkey COS cells. We show here that the LA45 gene is HLA-Aw66.2, a previously uncharacterized allele of the HLA-A locus. The previously determined LA45 sequence differs from that of HLA-Aw66.2, from HUT 102, and the CR-B B cell line derived from the same individual as HUT 102 by substitution of tryptophan for serine at position 4 in the alpha 1 domain. Transfection of HLA-Aw66.2, and of a mutant of this gene with serine 4 substituted for tryptophan, into a human B cell line (C1R) both resulted in expression of the LA45 epitope. Furthermore, we find expression of the LA45 epitope on Epstein Barr virus-transformed B cell lines as well as lectin-activated T cells, but not on long-term T cell lines or unstimulated peripheral blood T cells. The specificity of the LA45 antibody is polymorphic and the presence of the LA45 epitope is precisely correlated with the sequence arginine, asparagine (RN) at residues 62 and 63 of the helix of the alpha 1 domain. The LA45 epitope is broadly distributed, being associated with half the alleles of both HLA-A and -B loci but none of the HLA-C locus. All the results are consistent with the presence of pools of free HLA-A and -B heavy chains at the surfaces of certain cell types but not others. Such molecules are probably responsible for the HLA-associated class I alloantigens of lectin-activated T cells. We hypothesize the free heavy chains result from dissociation of beta 2-microglobulin from subpopulations of empty HLA-A,B molecules, or molecules with weakly bound peptides, that vary in size depending on cellular activation and peptide supply.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940790      PMCID: PMC2119017          DOI: 10.1084/jem.174.5.1085

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

Authors:  J J Neefjes; B S Breur-Vriesendorp; G A van Seventer; P Iványi; H L Ploegh
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

2.  The complete primary structure of HLA-Bw58.

Authors:  J P Ways; H L Coppin; P Parham
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

3.  New human MHC class I antigens segregating with HLA-A antigens detected on some lymphocyte subpopulations.

Authors:  Y Mitsuishi; A Falkenrodt; A Urlacher; M M Tongio; S Mayer
Journal:  Hum Immunol       Date:  1986-02       Impact factor: 2.850

4.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

5.  Biosynthesis of HLA-A and HLA-B antigens in vivo.

Authors:  M J Owen; A M Kissonerghis; H F Lodish
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

6.  A new HLA-A antigen, called LN, closely related to A25, A26 and Aw34.

Authors:  B Mesman; G de Lange; C P Engelfriet
Journal:  Tissue Antigens       Date:  1983-03

7.  Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens.

Authors:  M Gerbase de Lima; E E Wollman; V Lepage; L Degos; J Dausset
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

8.  Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.

Authors:  E Gazit; Y Gothelf; R Gil; S Orgad; T B Pitman; A L Watson; S Y Yang; E J Yunis
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

9.  New class I in man: serological and molecular characterization.

Authors:  R Fauchet; M Boscher; O Bouhallier; G Merdrignac; B Genetet; P Turmel; D J Charron
Journal:  Hum Immunol       Date:  1986-09       Impact factor: 2.850

10.  Exon shuffling in vivo can generate novel HLA class I molecules.

Authors:  N Holmes; P Parham
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  23 in total

1.  Polymorphic specificity of Q1/28, a monoclonal antibody that preferentially reacts with free class I heavy chains.

Authors:  R J Benjamin; J R Abrams; J R Parnes; J A Madrigal; P Parham
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Expression of beta 2-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers.

Authors:  W F Pickl; W Holter; J Stöckl; O Majdic; W Knapp
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  HLA-F complex without peptide binds to MHC class I protein in the open conformer form.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

Review 5.  Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin.

Authors:  J C Solheim; J R Cook; T H Hansen
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

6.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.

Authors:  M Colonna; G Borsellino; M Falco; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  MHCI negatively regulates synapse density during the establishment of cortical connections.

Authors:  Marian W Glynn; Bradford M Elmer; Paula A Garay; Xiao-Bo Liu; Leigh A Needleman; Faten El-Sabeawy; A Kimberley McAllister
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

8.  Membrane expression of HLA-Cw4 free chains in activated T cells of transgenic mice.

Authors:  A Aiuti; P Forte; L Simeoni; M Lino; L Pozzi; A Fattorossi; P Giacomini; E Ginelli; A Beretta; A Siccardi
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  The expression patterns of MHC class I molecules in the developmental human visual system.

Authors:  Aifeng Zhang; Hong Yu; Yuqing Shen; Jiane Liu; Youji He; Qian Shi; Bo Fu; Fengqin Miao; Jianqiong Zhang
Journal:  Neurochem Res       Date:  2012-11-04       Impact factor: 3.996

10.  Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg.

Authors:  M H Ravindranath; P I Terasaki; T Pham; V Jucaud; S Kawakita
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.